Thyroid Eye Disease (TED) Global Market Report 2025

Global Thyroid Eye Disease (TED) Market Report 2025

Thyroid Eye Disease (TED) Global Market Report 2025 - By Treatment Type (Medical, Surgical, Combination Of Medical And Surgical), By Disease Severity (Mild, Moderate, Severe), By Drug Type (Biologics, Small Molecules, Others Drug Type), By Route Of Administration (Oral, Intravenous, Subcutaneous), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Name: Thyroid Eye Disease (TED) Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Thyroid Eye Disease (TED) Global Market Report 2025

Report Price : $4490.00 | Pages : 175 | Published : March 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Thyroid Eye Disease (TED) Global Market Report 2025

Proud Members Of

What Is Covered Under Thyroid Eye Disease (TED) Market

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune condition characterized by inflammation and swelling of the tissues around the eyes, often associated with thyroid disorders. TED can cause symptoms such as bulging eyes, double vision, and eye pain.

The main treatment types of thyroid eye disease (TED) are medical, surgical, and a combination of medical and surgical approaches. Medical treatment of thyroid eye disease (TED) typically involves the use of corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, control symptoms, and prevent disease progression. It is tailored based on the disease severity, which can be classified into mild, moderate, and severe stages. Drugs used for treatment fall into different categories, including biologics, small molecules, and others. It is available in various routes of administration options, including oral, intravenous, and subcutaneous delivery methods and are used by several end users such as hospitals, clinics, and others.

How Is The Thyroid Eye Disease (TED) Market Segmented?

The thyroid eye disease (TED) market covered in this report is segmented –

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Others Drug Type

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

Thyroid Eye Disease (TED) Market Size and growth rate 2025 to 2029: Graph

What Is The Thyroid Eye Disease (TED) Market Size 2025 And Growth Rate?

The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising thyroid disorders, growing focus on patient-centered care, increasing demand for cosmetic procedures, increasing prevalence of the disease, and increasing treatment options for TED.

What Is The Thyroid Eye Disease (TED) Market Growth Forecast?

The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the increasing prevalence of Graves' disease, increasing funding in various industries, increasing healthcare expenditure, increasing use of thyroid hormone replacement therapy, and rising incidence of thyroid disease. Major trends in the forecast period include technological advancements, expanding R&D activities, development of novel drugs, advancements in treatment options, and new surgical techniques.

Book your 30 minutes free consultation with our research experts

What Is Driving The Thyroid Eye Disease (TED) Market: Thyroid Disorders And Their Influence On The Market Dynamics

Rising thyroid disorders are expected to propel the growth of the thyroid eye disease (TED) market going forward. Thyroid disorders are medical conditions that affect the function of the thyroid gland, leading to imbalances in hormone production and resulting in conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. Rising thyroid disorders are driven by factors such as increased iodine intake, autoimmune conditions, genetic predisposition, and greater awareness leading to improved diagnostic rates. Thyroid Eye Disease (TED) contributes to the rise in thyroid disorder cases, as it is a common and serious complication of Graves' disease, increasing the overall burden and awareness of thyroid-related conditions. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based non-profit, community-based organization, in 2024, an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada, with approximately 280 fatalities projected. Therefore, rising thyroid disorders are driving the growth of the thyroid eye disease (TED) market.

Who Are The Major Players In The Global Thyroid Eye Disease (TED) Market?

Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

What Are The Key Trends Of The Global Thyroid Eye Disease (TED) Market: Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment

Major companies operating in the thyroid eye disease (TED) market are focusing on innovative products, such as monoclonal antibody therapies, to develop more effective, targeted treatments that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies are treatments that use laboratory-made antibodies designed to mimic the immune system’s ability to target and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved TEPEZZA (teprotumumab) for treating active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. It is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly important for patients in Japan, as it provides a new, effective option to manage TED, a rare and progressive condition that causes debilitating eye bulging, vision problems, and eye pain.

What Are Latest Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market: Amgen Acquires Horizon Therapeutics To Strengthen Rare And Inflammatory Disease Portfolio

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. With this acquisition, Amgen aims to strengthen its rare and inflammatory disease portfolio by leveraging Horizon’s key therapies, expanding global reach, and accelerating innovation for long-term growth. Horizon Therapeutics plc is an Ireland-based company that specializes in rare autoimmune and inflammatory diseases.

What Is The Regional Outlook For The Global Thyroid Eye Disease (TED) Market?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thyroid eye disease (TED) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thyroid Eye Disease (TED) Market?

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Thyroid Eye Disease (TED) Industry?

The thyroid eye disease (TED) market research report is one of a series of new reports from The Business Research Company that provides thyroid eye disease (TED) market statistics, including the thyroid eye disease (TED) industry global market size, regional shares, competitors with the thyroid eye disease (TED) market share, detailed thyroid eye disease (TED) market segments, market trends, and opportunities, and any further data you may need to thrive in the thyroid eye disease (TED) industry. This thyroid eye disease (TED) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Thyroid Eye Disease TED Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.30 billion
Revenue Forecast In 2034	$2.97 billion
Growth Rate	CAGR of 6.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The thyroid eye disease (TED) market covered in this report is segmented – 1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical 2) By Disease Severity: Mild, Moderate, Severe 3) By Drug Type: Biologics, Small Molecules, Others Drug Type 4) By Route Of Administration: Oral, Intravenous, Subcutaneous 5) By End User: Hospitals, Clinics, Other End Users Subsegments: 1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments 2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery 3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Thyroid Eye Disease (TED) Market Characteristics

3. Thyroid Eye Disease (TED) Market Trends And Strategies

4. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Thyroid Eye Disease (TED) Growth Analysis And Strategic Analysis Framework

5.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Thyroid Eye Disease (TED) Market Growth Rate Analysis

5.4. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM)

6. Thyroid Eye Disease (TED) Market Segmentation

6.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medical

Surgical

Combination Of Medical And Surgical

6.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mild

Moderate

Severe

6.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biologics

Small Molecules

Others Drug Type

6.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Subcutaneous

6.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End Users

6.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Teprotumumab

Antithyroid Medications

Other Medical Treatments

6.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Orbital Decompression Surgery

Eyelid Surgery

Strabismus Surgery

6.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combination Of Corticosteroids And Orbital Decompression

Combination Of Teprotumumab And Eyelid Surgery

Other Combined Approaches

7. Thyroid Eye Disease (TED) Market Regional And Country Analysis

7.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Eye Disease (TED) Market

8.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Eye Disease (TED) Market

9.1. China Thyroid Eye Disease (TED) Market Overview

9.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Eye Disease (TED) Market

10.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Eye Disease (TED) Market

11.1. Japan Thyroid Eye Disease (TED) Market Overview

11.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Eye Disease (TED) Market

12.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Eye Disease (TED) Market

13.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Eye Disease (TED) Market

14.1. South Korea Thyroid Eye Disease (TED) Market Overview

14.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Eye Disease (TED) Market

15.1. Western Europe Thyroid Eye Disease (TED) Market Overview

15.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Eye Disease (TED) Market

16.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Eye Disease (TED) Market

17.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Eye Disease (TED) Market

18.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Eye Disease (TED) Market

19.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Eye Disease (TED) Market

20.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Eye Disease (TED) Market

21.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview

21.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Eye Disease (TED) Market

22.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Eye Disease (TED) Market

23.1. North America Thyroid Eye Disease (TED) Market Overview

23.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Eye Disease (TED) Market

24.1. USA Thyroid Eye Disease (TED) Market Overview

24.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Eye Disease (TED) Market

25.1. Canada Thyroid Eye Disease (TED) Market Overview

25.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Eye Disease (TED) Market

26.1. South America Thyroid Eye Disease (TED) Market Overview

26.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Eye Disease (TED) Market

27.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Eye Disease (TED) Market

28.1. Middle East Thyroid Eye Disease (TED) Market Overview

28.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Eye Disease (TED) Market

29.1. Africa Thyroid Eye Disease (TED) Market Overview

29.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

30.1. Thyroid Eye Disease (TED) Market Competitive Landscape

30.2. Thyroid Eye Disease (TED) Market Company Profiles

30.2.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Genentech Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Pierre Fabre S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

31.1. Innovent Biologics Inc.

31.2. ACELYRIN Inc.

31.3. Soleo Health

31.4. Zai Lab Limited

31.5. HanAll Biopharma Co. Ltd.

31.6. Tourmaline Bio Inc.

31.7. Zenas BioPharma Inc.

31.8. Immunovant Inc.

31.9. Verana Health

31.10. Harbour BioMed (Guangzhou) Co. Ltd.

31.11. Sling Therapeutics Inc.

31.12. Crinetics Pharmaceuticals Inc.

31.13. Lassen Therapeutics Inc.

31.14. Viridian Therapeutics Inc.

31.15. Minghui Pharmaceutical Inc.

32. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

34. Recent Developments In The Thyroid Eye Disease (TED) Market

35. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

35.1 Thyroid Eye Disease (TED) Market In 2029 - Countries Offering Most New Opportunities

35.2 Thyroid Eye Disease (TED) Market In 2029 - Segments Offering Most New Opportunities

35.3 Thyroid Eye Disease (TED) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Hoffmann-La Roche AG Financial Performance

Table 80: Amgen Inc. Financial Performance

Table 81: Genentech Inc. Financial Performance

Table 82: Horizon Therapeutics plc Financial Performance

Table 83: Pierre Fabre S.A. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical And Surgical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Hoffmann-La Roche AG Financial Performance

Figure 80: Amgen Inc. Financial Performance

Figure 81: Genentech Inc. Financial Performance

Figure 82: Horizon Therapeutics plc Financial Performance

Figure 83: Pierre Fabre S.A. Financial Performance

Global Hospital-Acquired Infection Control Market 2022 – Market Opportunities And Strategies

What Is The Healthcare IT Consulting Market Overview In 2022?

How Will The Stem Cell Assay Market Grow In 2022?

Latest Single Use Bioprocessing Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Thyroid Cancer Drugs Global Market Report 2025 – By Drug Type (Ipilimumab, Cabozantinib-S-Malate, Caprelsa (Vandetanib), Doxorubicin Hydrochloride, Lenvatinib Mesylate, Nivolumab, Vandetanib, Other Drug Types), By Type (Radioiodine Ablation, Thyroid Stimulating Hormone (THS) Suppression, Chemotherapy, Targeted Multikinase Therapy, Other Types), By End Users (Hospitals, Oncology Clinics, Research Organizations, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Anti-Thyroid Drugs Global Market Report 2025 – By Drug Type (Thionamides (Inhibition of hormone synthesis), Iodides (Inhibition of hormone release)), By Route of Administration (Oral, Intravenous, Other Route of Administration), By Distribution Channel (Wholesaler/Distributors, Retail Chain, Online Distribution, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Parathyroid Hormone Global Market Report 2025 – By Disease Type (Hypocalcemia, Hypoparathyroidism), By Product Type (Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues), By End-User (Hospitals, Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Thyroid Cancer Diagnostics Global Market Report 2025 – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Type), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End-User (Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Biomarkers Global Market Report 2025 – By Biomarker Type (Functional Biomarker, Up Regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)), By Application (Diagnosis And Disease Progression Monitoring, Research Homecare), By End User (Hospitals, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

End Stage Renal Disease (ESRD) Drug Global Market Report 2025 – By Product Type (Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders, Other Products), By Indication (End Stage Renal Disease (ESRD) Induced Hyperparathyroidism, End Stage Renal Disease (ESRD) Induced Hyperphosphatemia, End Stage Renal Disease (ESRD) Induced Hyperkaliemia), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Hepatorenal Syndrome Treatment Global Market Report 2025 – By Type (Type 1 Hepatorenal Syndrome, Type 2 Hepatorenal Syndrome), By Treatment (Therapeutics, Surgical Treatment), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Renal Denervation Devices Global Market Report 2025 – By Product (Simplicity Renal Denervation System, EnligHTN, Vessix Renal Denervation System, Iberis Renal Sympathetic Denervation System, Paradise Renal Denervation System, Other Products ), By Technology (Radio Frequency Ablation, Ultrasound Energy-Based RDN, Brachytherapy, Chemical Ablation, Other Technologies), By End-Users (Hospitals, Cardiovascular research center, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Thyroid Eye Disease (TED) market?

How will the Thyroid Eye Disease (TED) market drivers and restraints affect the market dynamics? What forces will shape the Thyroid Eye Disease (TED) industry going forward?

The Thyroid Eye Disease (TED) market major growth driver - Thyroid Disorders And Their Influence On The Market Dynamics. For further insights on the Thyroid Eye Disease (TED) market, request a sample here

What is the forecast market size or the forecast market value of the Thyroid Eye Disease (TED) market?

The Thyroid Eye Disease (TED) market size has grown strongly in recent years. The thyroid eye disease (TED) market size has grown strongly in recent years. It will grow from $2.15 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to rising thyroid disorders, growing focus on patient-centered care, increasing demand for cosmetic procedures, increasing prevalence of the disease, and increasing treatment options for TED. The thyroid eye disease (TED) market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to the increasing prevalence of Graves' disease, increasing funding in various industries, increasing healthcare expenditure, increasing use of thyroid hormone replacement therapy, and rising incidence of thyroid disease. Major trends in the forecast period include technological advancements, expanding R&D activities, development of novel drugs, advancements in treatment options, and new surgical techniques. For further insights on the Thyroid Eye Disease (TED) market, request a sample here

How is the Thyroid Eye Disease (TED) market segmented?

The thyroid eye disease (TED) market covered in this report is segmented –
1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical
2) By Disease Severity: Mild, Moderate, Severe
3) By Drug Type: Biologics, Small Molecules, Others Drug Type
4) By Route Of Administration: Oral, Intravenous, Subcutaneous
5) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments
2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery
3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches For further insights on the Thyroid Eye Disease (TED) market, request a sample here

Which region has the largest share of the Thyroid Eye Disease (TED) market? What are the other regions covered in the report?

Who are the major players in the Thyroid Eye Disease (TED) market?

What are the key trends in the Thyroid Eye Disease (TED) market?

Major trends in the Thyroid Eye Disease (TED) market include Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment. For further insights on the Thyroid Eye Disease (TED) market, request a sample here.

What are the major opportunities in the Thyroid Eye Disease (TED) market? What are the strategies for the Thyroid Eye Disease (TED) market?

For detailed insights on the major opportunities and strategies in the Thyroid Eye Disease (TED) market, request a sample here.

How does the Thyroid Eye Disease (TED) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Thyroid Eye Disease (TED) market growth and SWOT analysis of the Thyroid Eye Disease (TED) industry, request a sample here.

For detailed insights on Thyroid Eye Disease (TED)'s relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Thyroid Eye Disease (TED) industry? request a sample here.

For detailed insights on the mergers and acquisitions in the Thyroid Eye Disease (TED) industry,

What are the key dynamics influencing the Thyroid Eye Disease (TED) market growth? SWOT analysis of the Thyroid Eye Disease (TED) market. request a sample here.